What is ABPRO HLDGS INC's earnings per share (EPS)?

ABPRO HLDGS INC (ABP) reported diluted earnings per share of $-1.30 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

ABPRO HLDGS INC Financials

ABP

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows ABPRO HLDGS INC (ABP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ABP FY2025 2026-04-22

Abpro’s development-stage cost structure is being sustained by repeated financing rather than by commercial revenue or internal cash.

From FY2024 to FY2025, reported losses narrowed from -$7.2M to -$2.9M, but that accounting improvement did not repair the funding model. Liquidity still deteriorated because cash fell to $82K despite $3.1M of financing inflow, which means outside capital remained the practical source of survival.

The expense base still looks like a research organization rather than a scaled seller: in FY2024, revenue was only $183K while R&D reached $3.0M, and SG&A was larger still. That pattern says the company’s economics are currently driven more by development spending and corporate overhead than by product commercialization.

The balance sheet is structurally strained: FY2025 liabilities of $9.9M sat against only $1.1M of assets, with negative equity persisting across the reported years. A notable shift is that financing costs are now competing with development spend, as FY2025 interest expense of $1.1M exceeded R&D of $989K.

Financial Health Signals

Financial Profile 0/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of ABPRO HLDGS INC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Liquidity

ABPRO HLDGS INC's current ratio of 0.10 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Piotroski F-Score Weak

1/9

ABPRO HLDGS INC passes 1 of 9 financial strength tests. No profitability signals pass, 1 of 3 leverage/liquidity signals pass.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

-$2.9M

YoY+60.0%

ABPRO HLDGS INC reported -$2.9M in net income in fiscal year 2025. This represents an increase of 60.0% from the prior year.

EPS (Diluted)

$-1.30

ABPRO HLDGS INC earned $-1.30 per diluted share (EPS) in fiscal year 2025. This represents an increase of 94.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$82K

YoY-97.1%

ABPRO HLDGS INC held $82K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

ABPRO HLDGS INC had 3M shares outstanding in fiscal year 2025. This represents a decrease of 94.7% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

$989K

YoY-66.8%

ABPRO HLDGS INC invested $989K in research and development in fiscal year 2025. This represents a decrease of 66.8% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

ABP Income Statement

Metric	FY25	FY24	FY23	FY22
Revenue	N/A	$183K+50.0%	$122K	N/A
Cost of Revenue	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A
R&D Expenses	$989K-66.8%	$3.0M-30.1%	$4.3M	N/A
SG&A Expenses	N/A	$7.1M-6.3%	$7.6M	N/A
Operating Income	N/A	-$9.9M+15.5%	-$11.7M-472.9%	-$2.1M
Interest Expense	$1.1M+191.5%	$387K+1582.6%	$23K	N/A
Income Tax	N/A	N/A	$1.2M+42.9%	$824K
Net Income	-$2.9M+60.0%	-$7.2M-356.3%	$2.8M+218.1%	$887K
EPS (Diluted)	$-1.30	$-22.31-3557.4%	$-0.61	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	$243K-22.4%	$313K-3.7%	$325K	N/A	$642K-22.4%	$827K-17.3%	$1.0M
SG&A Expenses	N/A	$1.1M-43.9%	$1.9M-26.0%	$2.6M	N/A	$1.5M-2.7%	$1.5M-19.5%	$1.9M
Operating Income	N/A	-$1.3M+40.9%	-$2.3M+23.6%	-$3.0M	N/A	-$1.9M+17.5%	-$2.3M+18.7%	-$2.9M
Interest Expense	N/A	$193K+10.9%	$174K-76.4%	$737K	N/A	$164K+62.4%	$101K+140.5%	$42K
Income Tax	N/A	N/A	N/A	N/A	N/A	$28K+5.7%	$26K+532.2%	$4K
Net Income	N/A	-$1.7M+44.5%	-$3.0M+23.2%	-$3.9M	N/A	-$335K+1.1%	-$339K-208.6%	$312K
EPS (Diluted)	N/A	$-0.63	$-0.05+37.5%	$-0.08	N/A	$-3.27-2415.4%	$-0.13-1400.0%	$0.01

ABP Balance Sheet

Metric	FY25	FY24	FY23	FY22
Total Assets	$1.1M-77.2%	$4.7M+38.9%	$3.4M-98.9%	$310.6M
Current Assets	$896K-76.3%	$3.8M+85.6%	$2.0M+164.2%	$770K
Cash & Equivalents	$82K-97.1%	$2.9M+294.2%	$723K+84.2%	$392K
Inventory	N/A	N/A	N/A	N/A
Accounts Receivable	$183K0.0%	$183K+108.0%	$88K	N/A
Goodwill	N/A	N/A	N/A	N/A
Total Liabilities	$9.9M-49.5%	$19.6M-78.8%	$92.3M-71.3%	$321.7M
Current Liabilities	$9.3M-52.3%	$19.6M+24.6%	$15.7M+634.6%	$2.1M
Long-Term Debt	N/A	N/A	N/A	N/A
Total Equity	-$8.8M+43.0%	-$15.5M+82.6%	-$89.0M-696.0%	-$11.2M
Retained Earnings	-$119.0M-2.5%	-$116.1M-6.6%	-$108.9M-12.0%	-$97.2M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$1.1M-37.6%	$1.7M-51.1%	$3.5M+24.5%	$2.8M-40.0%	$4.7M-40.7%	$7.9M-0.5%	$7.9M+4.8%	$7.5M
Current Assets	$896K-26.9%	$1.2M-60.1%	$3.1M+38.3%	$2.2M-41.2%	$3.8M+142.0%	$1.6M+462.8%	$277K+976.6%	$26K
Cash & Equivalents	$82K-76.1%	$343K-83.1%	$2.0M+44.4%	$1.4M-50.7%	$2.9M+20860.5%	$14K-94.3%	$237K+2131.0%	$11K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$183K-32.5%	$271K-20.8%	$342K+3.3%	$331K+80.9%	$183K	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$9.9M-44.6%	$17.8M-14.9%	$21.0M-0.8%	$21.2M+7.9%	$19.6M-23.6%	$25.7M+1.5%	$25.3M+3.2%	$24.5M
Current Liabilities	$9.3M-46.0%	$17.3M-15.3%	$20.4M-0.9%	$20.6M+5.1%	$19.6M+116.9%	$9.0M+23.7%	$7.3M+10.6%	$6.6M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$8.8M+45.3%	-$16.1M+7.7%	-$17.5M+4.7%	-$18.4M-18.5%	-$15.5M+13.0%	-$17.8M-2.4%	-$17.4M-2.4%	-$17.0M
Retained Earnings	-$119.0M+4.5%	-$124.6M-1.3%	-$123.0M-2.5%	-$120.0M-3.3%	-$116.1M-3.0%	-$112.8M-548.2%	-$17.4M-2.4%	-$17.0M

ABP Cash Flow Statement

Metric	FY25	FY24	FY23	FY22
Operating Cash Flow	N/A	-$9.0M-22.0%	-$7.4M-524.7%	-$1.2M
Capital Expenditures	N/A	N/A	$48K	N/A
Free Cash Flow	N/A	N/A	-$7.5M	N/A
Investing Cash Flow	N/A	N/A	N/A	-$305.7M
Financing Cash Flow	$3.1M-72.5%	$11.2M+1214.6%	$849K-99.7%	$307.2M
Dividends Paid	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	$0

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$620K+72.8%	-$2.3M-64.6%	-$1.4M+19.4%	-$1.7M+54.9%	-$3.8M-282.6%	-$997K+27.2%	-$1.4M+51.9%	-$2.8M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	-$20K+33.3%	-$30K-100.1%	$29.7M
Financing Cash Flow	$359K-36.9%	$569K-71.7%	$2.0M+1422.7%	$132K-98.0%	$6.7M+612.2%	$936K-22.9%	$1.2M-48.2%	$2.3M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$29.7M

ABP Financial Ratios

Metric	FY25	FY24	FY23	FY22
Gross Margin	N/A	N/A	N/A	N/A
Operating Margin	N/A	-5421.3%+4206.6pp	-9627.9%	N/A
Net Margin	N/A	-3951.9%-6264.6pp	2312.7%	N/A
Return on Equity	N/A	N/A	N/A	N/A
Return on Assets	-272.1%-116.9pp	-155.2%-239.3pp	84.1%+83.8pp	0.3%
Current Ratio	0.10-0.1	0.19+0.1	0.13-0.2	0.36
Debt-to-Equity	-1.12+0.1	-1.27-0.2	-1.04+27.7	-28.78
FCF Margin	N/A	N/A	-6106.6%	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	-97.3%-11.6pp	-85.7%+53.3pp	-139.0%	N/A	-4.3%+0.0pp	-4.3%-8.4pp	4.1%
Current Ratio	0.10+0.0	0.07-0.1	0.15+0.0	0.11-0.1	0.19+0.0	0.17+0.1	0.04+0.0	0.00
Debt-to-Equity	-1.12-0.0	-1.11+0.1	-1.20-0.0	-1.15+0.1	-1.27+0.2	-1.44+0.0	-1.45-0.0	-1.44
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$8.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.10), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Biomx Inc PHGE

$7.5M

Adaptimmune Therapeutics Plc ADAP

$14.6M

APOLLOMICS INC APLM

$28.2M

Phio Pharmaceuticals Corp PHIO

$13.9M

Biocardia Inc BCDA

$12.5M

Frequently Asked Questions

Is ABPRO HLDGS INC profitable?

No, ABPRO HLDGS INC (ABP) reported a net income of -$2.9M in fiscal year 2025.

What are ABPRO HLDGS INC's total assets?

ABPRO HLDGS INC (ABP) had $1.1M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does ABPRO HLDGS INC spend on research and development?

ABPRO HLDGS INC (ABP) invested $989K in research and development during fiscal year 2025.

How many shares does ABPRO HLDGS INC have outstanding?

ABPRO HLDGS INC (ABP) had 3M shares outstanding as of fiscal year 2025.

What is ABPRO HLDGS INC's current ratio?

ABPRO HLDGS INC (ABP) had a current ratio of 0.10 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is ABPRO HLDGS INC's debt-to-equity ratio?

ABPRO HLDGS INC (ABP) had a debt-to-equity ratio of -1.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is ABPRO HLDGS INC's return on assets (ROA)?

ABPRO HLDGS INC (ABP) had a return on assets of -272.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is ABPRO HLDGS INC's debt-to-equity ratio negative or unusual?

ABPRO HLDGS INC (ABP) has negative shareholder equity of -$8.8M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is ABPRO HLDGS INC's Piotroski F-Score?

ABPRO HLDGS INC (ABP) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

How financially healthy is ABPRO HLDGS INC?

ABPRO HLDGS INC (ABP) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.